Consider adding this drug to fight COPD that's severe

Journal of Family Practice

Volumn 61, Issue 7, 2012, Pages 414-416

  Hobbs, Keia ^a   Brown, Dionna ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; GLUCOCORTICOID; MACROLIDE; OXYGEN; PLACEBO; TIOTROPIUM BROMIDE;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENERAL PRACTITIONER; HEALTH CARE COST; HEARING IMPAIRMENT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; RISK; RISK BENEFIT ANALYSIS; SHORT FORM 36; SMOKING; TABLET;

EID: 84879351870     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365:689-698.
2. Centers for Disease Control and Prevention. Injury prevention & control: data & statistics. Available at: http://www.cdc.gov/injury/wisqars/ LeadingCauses.html. Accessed April 16, 2012.
3. Perera PN, Armstrong EP, Sherrill DL, et al. Acute exacerbations of COPD in the United States: inpatient burden and predictors of cost and mortality. COPD. 2012;9:131-141.
4. Jenkins CR, Jones PW, Calverley PM, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res. 2009;10:59.
5. Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT); a prespecified subgroup analysis of a randomized controlled trial. Lancet.2009;374:1171-1178.
6. Black PN, Staykova T, Chacko EE, et al. Prophylactic antibiotic therapy for chronic bronchitis. Cochrane Database Syst Rev. 2003;(1):CD004105.
7. Southern KW, Barker PM, Solis-Moya A, et al. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2011;(12):CD002203.
8. Seemungal TA, Wilkinson TM, Hurst JR, et al. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary exacerbations. Am J Respir Crit Care Med. 2008;178:1139-1147.
9. Yamaya A, Azuma A, Tanaka H, et al. Inhibitory effects of macrolides on exacerbations and hospitalization in chronic obstructive pulmonary disease in Japan: a retrospective multicenter analysis. J Am Geriatri Soc. 2008;56:1358-1360.
10. www.Drugstore.com. Accessed March 28, 2012.